ERISA Industry Committee applauds FDA efforts to make biosimilars more accessibleThe ERISA Industry Committee calls the effort to update interchangeability guidance a positive step. Kroger files lawsuit against FTC Kroger is suing the FTC, seeking to block the agency from reviewing its proposed merger with Albertsons. Alembic receives FDA OK for generic Pradaxa Dabigatran Etexilate capsules are indicated for prophylaxis of deep vein thrombosis and pulmonary embolism following hip replacement surgery. Kroger reportedly planning to double proposed price cuts upon merger completion According to a report, the grocer intends to double its proposed price cuts upon the completion of the $25.6 billion deal. NACDS CEO reiterates association’s fight against PBMs, makes push for provider status The way pharmacies are paid for medications is an antiquated model and ignorant of the vital role of the pharmacist, Anderson said. AAM, Biosimilars Forum call on CMS to support lower-cost biosimilars, increase access for patients AAM and The Biosimilars Forum state that the uncertainty created by the IRA harms generic and biosimilar competition. Novartis loses initial bid to block MSN's generic Entresto MSN's version of the heart failure drug Entresto would be the first U.S. generic of the drug. NACDS TSE political event to feature Morning Consult’s Eli Yokley The Political Involvement Reception will be held Aug. 17, from 5:00 pm to 6:00 pm EST. Novartis files lawsuit against FDA over generic Entresto The complaint follows the FDA granting permission to MSN Laboratories for an Entresto generic product. Alembic receives FDA OK for generic Prolixin Fluphenazine hydrochloride tablets are indicated in the management of manifestations of psychotic disorders. First Previous 7 8 9 10 11 Next Last
